One-stage Bone Lengthening in the Management of Brachymetatarsia

Cosmetic Satisfaction and Undercorrection After One-stage Bone Lengthening in the Management of Brachymetatarsia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04287127

Acronym

BRACHYONESTAGE

Enrollment

Registered

2020-02-27

Start date

2019-01-01

Completion date

2020-01-01

Last updated

2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachymetatarsia

Brief summary

Brachymetatarsia is a shortening in length of a metatarsal exceeding 5mm. This congenital anomaly most often affecting women and the second metatarsal is associated with frequent aesthetic disorders leading patients to consult. The one-time lengthening technique is described for the management of brachymetatarsia with good functional results. However, the metatarsal elongation in one time is limited to 15 millimeters, to avoid complications. No study has presented the consequences of hypocorrection, especially cosmetic. Our hypothesis is that undercorrection (Hypocorrection) is associated with a higher rate of cosmetic dissatisfaction.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients operated on for a one-time lengthening for isolated brachymetatarsia * Major patients

Exclusion criteria

* Patient refusing to participate in research

Design outcomes

Primary

Measure	Time frame	Description
satisfaction using a visual analog scale (from 0/10 to 10/10)	1 day	Cosmetic evaluation

Secondary

Measure	Time frame	Description
radiological evaluation of surgical correction	1 day	metatarsal lengtening : mesured on a dorsoplantar radiograph

Countries

France

Outcome results